Evidence map›Paper›PMID 42298567›Full record

ArticleBMC biology2026

Uterine microbiome signatures associated with endometriosis.

Libo Zhu, Jiaying He, Xiaochun Xu, Shen Lu, Yanqin Yu, Wing Hing Wong, Farideh Z Bischoff, Xinmei Zhang

Abstract read
In one paragraph

Article in BMC biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Libo Zhu *School of Medicine, Women's Hospital, Zhejiang University, Hangzhou, China.
Jiaying He *HerAnova Lifesciences, Hangzhou, China.
Xiaochun XuHerAnova Lifesciences, Hangzhou, China.
Shen LuHerAnova Lifesciences, Hangzhou, China.
Yanqin YuHerAnova Lifesciences, Hangzhou, China.
Wing Hing WongHerAnova Lifesciences, Burlington, MA, 01803, USA. wing.h.wong@heranova.com.
Farideh Z BischoffHerAnova Lifesciences, Burlington, MA, 01803, USA. farideh.bischoff@heranova.com.
Xinmei ZhangSchool of Medicine, Women's Hospital, Zhejiang University, Hangzhou, China. zhangxinm@zju.edu.cn.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundEndometriosis is a chronic inflammatory disorder affecting ~ 10% of reproductive-age women, often causing pelvic pain and infertility. Despite its prevalence, diagnosis remains delayed due to non-specific symptoms and lack of reliable non-invasive biomarkers. Emerging evidence implicates the microbiome in disease pathogenesis.

resultsWe analyzed uterine microbiomes from 266 tissue samples collected during either the proliferative or secretory phase, using 16S rRNA gene sequencing. Genus-level analysis revealed variable Lactobacillus abundance among all individuals. Prevotella showed borderline enrichment in proliferative-phase patients. Sub-genus analyses identified a small number of differentially abundant taxa, though none remained significant after FDR correction. To capture subtle microbial shifts, we developed a feature set combining weakly differential taxa, algorithmically selected taxa via machine learning, and a functional dysbiosis score. A supervised classifier trained on proliferative-phase data achieved moderate predictive performance (AUC = 0.70), while secretory-phase models performed more poorly (AUC = 0.58).

conclusionsThe uterine microbiome shows phase-dependent differences in its potential to inform endometriosis status. Although no robust individual microbial biomarkers were identified, machine learning models incorporating subtle community features from the proliferative phase yielded modest diagnostic potential. These results highlight the importance of menstrual cycle-aware sampling and support further development of microbiome-informed diagnostic tools for endometriosis.

Indexed as

EndometriosisMicrobiotaUterusFemaleHumansMachine LearningRNA, Ribosomal, 16SRNA, Ribosomal, 16SChronic inflammatory disorderDiagnosticsEndometriosisMachine learningUterine microbiomes

Identifiers

PMID42298567
PMCPMC13540929

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.